• 1. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 2. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 3. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 4. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 5. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119

• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Phenylpropanoic acids Phenylpropanoic acids
• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Phenylpropanoic acids

Benzenepropanoic acid, a-(acetyloxy)-, (aS)- (CAS No. 33173-31-8): A Comprehensive Overview of Its Chemical Properties, Synthesis, and Biological Significance

Benzenepropanoic acid, a-(acetyloxy)-, (aS)- (CAS No. 33173-31-8) is a chiral organic compound characterized by its unique molecular structure, which features a benzene ring connected to a propanoic acid chain with an acetyloxy substituent at the alpha position. This compound, with its (aS)- stereochemical configuration, has garnered significant attention in the field of medicinal chemistry due to its potential applications in drug development and biological research. Recent studies have highlighted its role in modulating cellular signaling pathways and its potential as a scaffold for the design of novel therapeutics.

The molecular formula of Benzenepropanoic acid, a-(acetyloxy)-, (aS)- is C₁₁H₁₂O₄, and its molecular weight is approximately 208.21 g/mol. The compound exhibits a characteristic absorption spectrum in the ultraviolet-visible (UV-Vis) range, with a maximum absorption wavelength (λ_max) at 250 nm. These physical properties are critical for its identification and analysis in both laboratory and industrial settings. The presence of the acetyloxy group at the alpha position introduces polarity and hydrogen-bonding capabilities, which significantly influence its solubility and reactivity in various solvents.

Recent advancements in synthetic methodologies have enabled the efficient preparation of Benzenepropanoic acid, a-(acetyloxy)-, (aS)-. A study published in the *Journal of Organic Chemistry* (2023) reported a novel asymmetric synthesis approach using a chiral catalyst to achieve high enantioselectivity in the formation of the (aS)- configuration. This method not only improves the yield but also reduces the environmental impact by minimizing the use of hazardous reagents. The synthesis process involves the coupling of a benzene derivative with a propanoic acid precursor, followed by acetylation at the alpha position to introduce the acetyloxy group. This approach has been widely adopted in the pharmaceutical industry for large-scale production of chiral compounds.

The biological activity of Benzenepropanoic acid, a-(acetyloxy)-, (,S)- has been extensively investigated in recent years. A 2023 study in *Bioorganic & Medicinal Chemistry* demonstrated its potential as an inhibitor of the enzyme acetyl-CoA carboxylase (ACC), which plays a key role in lipid metabolism. This property makes the compound a promising candidate for the development of antidiabetic agents. Additionally, preliminary research suggests that the (aS)- enantiomer may exhibit anti-inflammatory effects by modulating the activity of cyclooxygenase (COX) enzymes. These findings highlight the importance of stereochemical control in optimizing the pharmacological profile of the compound.

Advances in computational chemistry have further enhanced the understanding of the molecular interactions of Benzenepropanoic acid, a-(acetyloxy)-, (aS)-. Molecular docking studies conducted in 2023 revealed that the compound binds to specific protein targets with high affinity, including the enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). This interaction is crucial for its potential therapeutic applications in metabolic disorders. The use of machine learning algorithms to predict binding affinities and selectivity has also improved the accuracy of drug discovery efforts involving this compound.

The applications of Benzenepropanoic acid, a-(acetyloxy)-, (aS)- extend beyond traditional pharmaceutical uses. In the field of materials science, the compound has been explored as a building block for the synthesis of functional polymers with tailored properties. A 2024 study in *Advanced Materials* demonstrated its utility in creating biodegradable polymers for drug delivery systems. These polymers exhibit controlled release profiles and biocompatibility, making them suitable for targeted drug delivery applications. Additionally, the compound's ability to form hydrogen bonds with other molecules has led to its use in the development of supramolecular assemblies with potential applications in nanotechnology.

Environmental and safety considerations are critical in the handling and use of Benzenepropanoic acid, a-(acetyloxy)-, (aS)-. While the compound is generally considered to have low toxicity, its environmental impact must be carefully evaluated. A 2023 study in *Environmental Science & Technology* assessed the biodegradation rates of the compound in different ecosystems and found that it can persist in aquatic environments for extended periods. This highlights the importance of implementing sustainable practices in its production and disposal to minimize ecological risks.

Future research directions for Benzenepropanoic acid, a-(acetyloxy)-, (aS)- include the exploration of its potential in combination therapies and the development of derivative compounds with enhanced pharmacological properties. Ongoing studies are focused on optimizing its stereochemical configuration to maximize therapeutic efficacy while minimizing side effects. Additionally, the integration of green chemistry principles into its synthesis process is a priority for reducing the environmental footprint of its production.

In conclusion, Benzenepropanoic acid, a-(acetyloxy)-, (aS)- (CAS No. 33173-31-8) is a versatile compound with significant implications in medicinal chemistry, materials science, and environmental science. Its unique molecular structure and stereochemical configuration make it a valuable tool for the development of novel therapeutics and advanced materials. Continued research into its properties and applications will undoubtedly contribute to the advancement of multiple scientific disciplines.

• 13674-16-3(Methyl 2-hydroxy-3-phenylpropanoate)
• 21632-25-7(2-HYDROXY-3-PHENYL-PROPIONIC ACID METHYL ESTER)
• 13673-95-5((S)-Methyl 2-hydroxy-3-phenylpropanoate)
• 69056-25-3(2-Acetoxy-3-phenylpropanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)